Karyopharm and Menarini Group Enter into Exclusive License Agr...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEWTON, Mass. and FLORENCE, Italy, Dec. 21, 2021 /PRNewswire-AsiaNet/ -- - Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries- Karyopharm to Receive $7...
Authors: LATEST ASIANET NEWS RELEASES